-
Vollering wins Tour de France Femmes after war of nerves
-
BMW iX3 Flow Edition brings animated bodywork closer to reality
-
BMW’s next chapter accelerates with New Class rollout
-
Arteta backs Guimaraes to 'ignite something different' at Arsenal
-
Five dead in new Russia, Ukraine strikes
-
Como sign England defender Chalobah from Chelsea
-
PSG sign France full-back Digne from Villa
-
Demi Vollering wins Tour de France Femmes
-
Sinner withdraws from Cincinnati Open with knee injury
-
Iraola's first Anfield match as Liverpool manager ends in Monaco defeat
-
Fernandez's 'perfect' race earns him British MotoGP Grand Prix win
-
Bodies hanging from bridge revive violence in once-calm town in Mexico
-
Iran Guards say won't reopen Hormuz without US meeting Tehran's demands
-
Lionel Messi bids farewell to father who guided his glittering career
-
Hogh's hat-trick inspires Celtic to 5-1 victory over Kilmarnock
-
Raul Fernandez wins British MotoGP Grand Prix
-
London grants first licences for supervised Uber robotaxis
-
Tesla FSD secrecy puts Europe’s safety oversight under scrutiny
-
Erasmus hopeful Kolisi hamstring injury not 'too bad'
-
Mercedes-AMG GT 53 balances speed, range and daily usability
-
Luxury car buyers trade prestige for mainstream value
-
Lion queen Werro focused on Euro medal, not 800m world record
-
Students, teachers mourn girl killed in Thailand school shooting
-
Changan uses FILDA 2026 to accelerate its African expansion
-
Jacobson to lead New Zealand for first time against Sharks
-
Honda plots a profitable European comeback without a price war
-
Typhoon Dolphin makes landfall in China after flight cancellations, evacuations
-
Iran Guards say won't reopen Hormuz without US meeting all Tehran's conditions
-
South Korea FA apologises after sex scandal adds to controversies
-
Messi absent after father's death as Miami lose in Leagues Cup
-
Indonesia closes national park as wildfire spreads
-
Flight cancellations, evacuations in China as Typhoon Dolphin looms
-
ZXMoto leads China's charge to dominate the global motorbike market
-
Iran issues demands for reopening of Hormuz
-
Top-ranked Sabalenka, Pegula stunned in Toronto fourth round
-
Afghanistan's gold rush upends lives and landscapes
-
Japan nuclear debate unnerves proponents of pacifism
-
Messi missing after father's death as Miami lose in Leagues Cup
-
Spanish teen Jodar ousts eighth seed Lehecka at Montreal
-
World number one Sabalenka ousted in Toronto by Alexandrova
-
Angers mounts in US over vast network of car license plate cams
-
Olympic weightlifter hoists debris for Venezuela earthquake recovery
-
Darderi to face Nakashima in Montreal quarter-finals
-
FIFA condemns 'concerted and ongoing effort' to weaken Infantino
-
Espresso power fires Darderi past Borges in Montreal
-
South Africa win after surviving late Argentina surge
-
Shnaider upsets Pegula to book Toronto quarter-final with Swiatek
-
Man Utd boss Carrick being 'careful' with Mount as Man Utd draw with PSG
US overdose capital Baltimore on long road to recovery
Carrying a bag filled with the overdose-reversing drug naloxone, Adam Trionfo roams the brick-lined streets of one of America's oldest port cities, Baltimore.
The 40-year-old and his small team visit neighborhoods considered "hot spots" for drug trafficking to hand out the precious antidote, sold under the brand name Narcan.
The easy-to-use nasal spray has become a key tool in the fight against the deadly US opioid crisis, claiming 750,000 lives between the late 1990s and 2022.
"Just over the past week, we distributed 200 Narcan kits," Trionfo, who oversees an addiction assistance program with the local branch of Catholic Charities, told AFP.
On their route, the team spots a man sprawled out amid a pile of rubbish in the corner of a stairwell. They hand him a box of Narcan and a brochure about their organization.
The man takes it with one hand, as he awkwardly hides a syringe behind his back.
Their last Narcan kit goes to another man, legs covered in brown scars, who is waiting near a dilapidated building.
These scenes are not uncommon in this East Coast city, which is located about 50 kilometers (31 miles) from Washington and is renowned for endemic crime.
Baltimore was the setting of the hit television series "The Wire" in the early 2000s, depicting its burgeoning drug scene from a variety of angles.
And last year, the New York Times dubbed the city the "American overdose capital."
Between 2018 and 2022, the drug-related mortality rate was nearly twice as high as in any other major American city. The leading killer: fentanyl.
- 'Tremendous efforts' -
Since the height of the opioid crisis in 2021, the outlook has improved in much of the country, including in Baltimore.
The number of fatal overdoses in the city plummeted by 35 percent last year, to 680 down from 1,043 in 2023.
The city's proactive policies, coupled with preventative work done by Catholic charities in Baltimore's communities have helped make a dent in the problem.
"We've had tremendous efforts throughout the city to get people into treatment, and then we've also had tremendous efforts in getting Naloxone out there," said Michael Fingerhood, head of addiction medicine at Johns Hopkins Bayview Medical Center.
Distributed broadly for about a decade, Narcan has worked like a "fire extinguisher," Fingerhood said.
In Baltimore, Narcan is now available everywhere: pharmacies, vending machines throughout the city, even in libraries.
- Funded by restitution -
The drop in mortality in Baltimore is also linked to the composition of the fentanyl being sold there, Fingerhood said.
"The drug supply has less potent fentanyl and has additives that are less likely to cause overdose."
Awareness of the risks associated with the powerful synthetic opioid has also grown among users, pushing them to be more "cautious," said Bakari Atiba, community engagement director at Charm City Care Connection.
The nonprofit assists addicts in Baltimore -- known as Charm City -- and recently received funding from a restitution program fueled by lawsuits against opioid manufacturers and distributors.
"I'm not saying people are going to stop using," Atiba said. "That's not even our goal."
"It's about meeting people where they are, making sure they're safe, making sure they're supported, and making sure they have pathways to recovery if they want it."
K.Brown--BTB